Literature DB >> 1910013

Influence of major histocompatibility complex haplotype on the mitogenic response of T cells to staphylococcal enterotoxin B.

J H Robinson1, G Pyle, M A Kehoe.   

Abstract

The abilities of antigen-presenting cells (APC) from nine independent major histocompatibility complex haplotypes and a number of intra-H-2 recombinant congenic strains of mice to present staphylococcal enterotoxin B (SEB) and induce proliferation in murine T-cell receptor V beta 8+ T-cell clones were compared. SEB presented by APC of all haplotypes tested induced significant responses in each of the T-cell clones. The magnitude of response was similar for most haplotypes, but there were limited quantitative differences between certain haplotypes. SEB presented by APC from H-2b mice as well as the intra-H-2 recombinant strains B10.GD and B10.A(4R), which do not express cell surface I-E (designated I-E-), induced the poorest T-cell responses. However, APC from AfE-, AsE-, and AqE- mice were as potent in SEB presentation as APC expressing both I-A and I-E. Antibodies against I-E were more effective than anti-I-A antibodies at inhibiting responses to SEB presented by APC expressing both I-A and I-E, whereas responses induced by APC expressing I-A but not I-E were blocked by antibodies against I-A. Thus, our results show that I-A can present SEB efficiently but that expression of both I-A and I-E on the same APC results in presentation of SEB predominantly by I-E. In addition, experiments using four distinct I-E- strains of mice indicate that I-A alleles differ in their ability to present SEB.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910013      PMCID: PMC258936          DOI: 10.1128/iai.59.10.3667-3672.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  T-cell responses to Mls and to bacterial proteins that mimic its behavior.

Authors:  C A Janeway; J Yagi; P J Conrad; M E Katz; B Jones; S Vroegop; S Buxser
Journal:  Immunol Rev       Date:  1989-02       Impact factor: 12.988

2.  Cell surface molecules involved in early events in T-cell mitogenic stimulation by staphylococcal enterotoxins.

Authors:  S M Vroegop; S E Buxser
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

3.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays.

Authors:  G A Bohach; B N Kreiswirth; R P Novick; P M Schlievert
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

5.  Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1.

Authors:  M F Rizkallah; A Tolaymat; J S Martinez; P M Schlievert; E M Ayoub
Journal:  Am J Dis Child       Date:  1989-07

6.  V beta-specific stimulation of human T cells by staphylococcal toxins.

Authors:  J Kappler; B Kotzin; L Herron; E W Gelfand; R D Bigler; A Boylston; S Carrel; D N Posnett; Y Choi; P Marrack
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

7.  The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

Authors:  J White; A Herman; A M Pullen; R Kubo; J W Kappler; P Marrack
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

8.  Predominant role of amino-terminal sequences in dictating efficiency of class II major histocompatibility complex alpha beta dimer expression.

Authors:  A J Sant; N S Braunstein; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Authors:  B Fleischer; H Schrezenmeier
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Dissociation of the stimulatory activities of staphylococcal enterotoxins for T cells and monocytes.

Authors:  D Grossman; R G Cook; J T Sparrow; J A Mollick; R R Rich
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  5 in total

1.  Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.

Authors:  B C Cole; A D Sawitzke; E A Ahmed; C L Atkin; C S David
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells.

Authors:  Courtney E Meilleur; Christine M Wardell; Tina S Mele; Jimmy D Dikeakos; Jack R Bennink; Hong-Hua Mu; John K McCormick; S M Mansour Haeryfar
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

3.  Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.

Authors:  R H See; W W Kum; A H Chang; S H Goh; A W Chow
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Hock immunization: a humane alternative to mouse footpad injections.

Authors:  T Kamala
Journal:  J Immunol Methods       Date:  2007-08-28       Impact factor: 2.303

5.  Discordant rearrangement of primary and anamnestic CD8+ T cell responses to influenza A viral epitopes upon exposure to bacterial superantigens: Implications for prophylactic vaccination, heterosubtypic immunity and superinfections.

Authors:  Courtney E Meilleur; Arash Memarnejadian; Adil N Shivji; Jenna M Benoit; Stephen W Tuffs; Tina S Mele; Bhagirath Singh; Jimmy D Dikeakos; David J Topham; Hong-Hua Mu; Jack R Bennink; John K McCormick; S M Mansour Haeryfar
Journal:  PLoS Pathog       Date:  2020-05-20       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.